DNA vaccines have been approved for two clinical human trials for Zika vaccines. An m-RNA vaccine and a vaccine created with an inactive version of the virus are two other vaccines in the animal testing phase. Vaccine with DNA The DNA vaccines use a little bit of DNA that is free of the virus's infectious components. This vaccination is designed to give the recipient cell-mediated protection to the virus. This sort of immunisation has the advantage of being able to treat immunocompromised people who would otherwise be unable to receive standard vaccines. mRNA Vaccine is a type of vaccine that uses mRNA to protect The m-RNA vaccine, also known as messenger RNA, transfers genetic information to cells, triggering an immunological response. The advantage of this technology is that it does not require the Zika Virus to be generated; only the sequencing is required. This allows for a faster vaccine production turnaround time. Virus Vaccine (Attenuated and Inactive) These vaccines frequently involve a virus that has died or has been attenuated, which is then delivered into the body to stimulate an immune response. Viruses that have been weakened are known as attenuated viruses.
Read More:
https://cmitoc.blogspot.com/2022/06/zika-vaccines-are-widely-being.html
